Panel Discussion: Biologics and biosimilars: The next leap in patient-centric drug development
The panel discussion titled ‘Biologics and Biosimilars: The Next Leap in Patient-Centric Drug Development’ at the FDD Conclave…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Ashok Omray
Panel Discussion : Bridging gaps in disease management
The COVID-19 pandemic has accelerated progress in formulation development and drug delivery. For instance, as scientists and…
Expiry and shelf life of drug products
Dr Ashok Omray, Advisor Pharma Operations, Ex AVP, USV and Ex-President, ICPL, comprehensively explains the relevance and…
Industry lauds move to allow import of drugs with 60 per cent residual shelf life
The pharma industry has lauded the Central Drugs Standard Control Organisation (CDSCO’s) recent move to allow the import of drugs…
Intraspheres TA as functional starter core for ER Formulations
The first speaker for this session, Dr Ashok Omray, President, Ideal Cures took the stage to set the context for the topic…